Abstract
Purpose. The aim of the study was to investigate whetherdopamine is transferred along the olfactory pathway to the brain followingnasal administration to mice.
Methods. [3H]-Dopamine was administered nasally or intravenouslyto female mice. Brain tissue samples were excised and the radioactivecontent was measured. The precise localisation of dopamineradioactivity in the brain was studied using autoradiography. The presence ofdopamine or its metabolites in the olfactory bulb and mucosa wasascertained using thin layer chromatography (TLC).
Results. After administration of [3H]-dopamine into the rightnostril, the amount of dopamine in the right bulb increased with time until,after 4 h, it was 27 times higher than in the left bulb. Among the otherbrain tissue samples, significantly higher amount of radioactivity wasdetected in the lateral olfactory tract. Radioactivity in the right olfactorybulb was shown by autoradiography to be selectively located in theperipheral layers 1 to 4 h after administration. Selective uptake ofradioactivity was not seen in other regions of the brain. TLC dataindicated that approximately 75% and 10% of the radioactivity in theolfactory bulb and mucosa, respectively, coeluted with dopamine.
Conclusions. The results indicate that unchanged dopamine istransferred into the olfactory bulb following nasal administration of[3H]-dopamine.
Similar content being viewed by others
REFERENCES
N. Geurkink. Nasal anatomy, physiology and function. J. Allergy Clin. Immunol. 72:123–128 (1983).
L. C. Uraih and R. R. Maronpot. Normal histology of the nasal cavity and application of special techniques. Environment. Health Perspect. 85:187–208 (1990).
S. Mathison, R. Nagilla, and U. B. Kompella. Nasal route for direct delivery of solutes to the central nervous system: fact or fiction? J. Drug Target. 5:415–441 (1998).
W. H. Frey, J. Liu, X. Chen, R. G. Thorne, J. R. Fawcett, T. A. Ala, and Y.-E. Rahman. Delivery of 125I-NGF to the brain via the olfactory route. Drug Deliv. 4:87–92 (1997).
K.-J. Chou and M. D. Donovan. The distribution of local anaesthetics into the CSF following intranasal administration. Int. J. Pharm. 168:137–145 (1998).
J. Henriksson and H. Tjälve. Uptake of inorganic mercury in the olfactory bulbs via olfactory pathways in rats. Environ. Res. 77:130–140 (1998).
E. B. Brittebo and C. Eriksson. Taurine in the olfactory system: effects of the olfactory toxicant dichlobenil. Neurotoxicology 16:271–280 (1995).
Y. Wang, R. Aun, and F. L. S. Tse. Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat. Biopharm Drug Dispos 19:571–575 (1998).
C. Eriksson, U. Bergman, A. Franzén, M. Sjöblom, and E. B. Brittebo. Transfer of some carboxylic acids in the olfactory system following intranasal administration. J. Drug Target. 7:131–142 (1999).
T. Yajima, K. Juni, M. Saneyoshi, T. Hasegawa, and T. Kawaguchi. Direct transport of 2',3'-didehydro-3'-deoxythymidine (D4T) and its ester derivatives to the cerebrospinal fluid via the nasal mucous membrane in rats. Biol. Pharm. Bull. 21:272–277 (1998).
E. M. Barnett and S. Perlman. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology 194:185–191 (1993).
B. S. Huneycutt, I. V. Plakhov, Z. Shusterman, S. M. Bartido, A. Huang, C. S. Reiss, and C. Aoki. Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis. Brain Res. 635:81–95 (1994).
R. G. Thorne, C. R. Emory, T. A. Ala, and W. I. Frey. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res. 692:278–282 (1995).
K. Kristensson and Y. Olsson. Uptake of exogenous proteins in mouse olfactory cells. Acta Neuropathol. 19:145–154 (1971).
P. Löwhagen, B. B. Johansson, and C. Nordborg. The nasal route of cerebrospinal fluid in man. A light-microscope study. Neuropathol. Appl. Neurobiol. 20:543–550 (1994).
R. Pietrowsky, C. Strüben, M. Mölle, H. L. Fehm, and J. Born. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans. Biol. Psychiatry 39:332–340 (1996).
R. Pietrowsky, A. Thiemann, W. Kern, H. L. Fehm, and J. Born. A nose-brain pathway for psycotropic peptides: evidence from a brain evoked potential study with cholestokinin. Psychoneuroendocrinology 21:559–572 (1996).
S. Okuyama. The first attempt at radioisotopic evaluation of the integrity of the nose-brain pathway. Life Sci. 60:1881–1884 (1997).
K. Ikeda, K. Murata, M. Kobayashi, and K. Noda. Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem. Pharm. Bull. 40:2155–2158 (1992).
H. P. Rang, M. M. Dale, and J. M. Ritter. Pharmacology. 4 ed. Edinburgh, Churchill Livingstone, 1999.
W. C. Koller and M. G. Ruedea. Mechanism of action of dopaminergic agents in Parkinson's disease. Neurology 50:S11–S14 (1998).
D. E. Dluzen and G. Kefalas. The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice. Brain Res. 741:215–219 (1996).
E. A. Gross, J. A. Swenberg, S. Fields, and J. A. Popp. Comparative morphometry of the nasal cavity in rats and mice. J. Anat. 135:83–88 (1982).
J. P. Schreider. Comparative anatomy and function of the nasal passages, In C. S. Barrow (ed.) Toxicology of the nasal passages, Hemisphere Publishing Corporation, Washington, 1986, pp. 1–25.
K. Chobotská, M. Arnold, P. Werner, and V. Pliska. A rapid assay for tyrosine hydroxylase activity, an indicator of chronic stress in laboratory and domestic animals. Biol. Chem. 379:59–63 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dahlin, M., Bergman, U., Jansson, B. et al. Transfer of Dopamine in the Olfactory Pathway Following Nasal Administration in Mice. Pharm Res 17, 737–742 (2000). https://doi.org/10.1023/A:1007542618378
Issue Date:
DOI: https://doi.org/10.1023/A:1007542618378